A new international research collaboration is advancing the field of precision medicine for inflammatory bowel disease (IBD), bringing together scientists from institutions including the Icahn School of Medicine at Mount Sinai in New York and King Saud University Medical City in Riyadh to better understand the genetic and environmental drivers of conditions such as Crohn's disease and ulcerative colitis. The partnership will analyse clinical data and biological samples from families affected by IBD to identify biomarkers and molecular signals that influence how the disease develops and progresses, with the goal of enabling earlier diagnosis and more personalised treatments tailored to individual patients. Researchers say the project could improve the ability to predict disease risk and guide targeted therapies, representing a significant step toward more precise, patient-specific care for chronic inflammatory disorders of the digestive system.
From the Medical Directory library. For advice about your own health, speak to your healthcare professional.
JOIN THE CONVERSATION
No comments yet. Add a thoughtful question or comment about this article.